Interventional Radiology

Yale New Haven Hospital interventional radiologists are recognized as pioneers in the field of interventional and therapeutic radiology specializing in image-guided, minimally invasive and hybrid medical procedures for the diagnostic and therapeutic benefit of our patients.

Procedures they perform include biopsies, embolization to block tumor growth or abnormal blood vessels, minimally invasive delivery of targeted chemotherapy or radiation to specific organs, and arteriography and angioplasty/stenting to impaired vessels in the viscera and periphery for occlusive and aneurysmal diseases.

Unique procedures that are performed by this section include uterine fibroid embolization (UFE), prostate artery embolization (PAE) for benign prostatic hyperplasia (enlarged prostate), pediatric interventions, varicose vein ablation and pain care including spine interventional procedures. Care for liver, lung and kidney cancers includes chemoembolization, radioembolization and percutaneous ablations of tumors in solid organs. For patients with a pulmonary embolism (a blood clot that has traveled to the lungs), a minimally invasive procedure of embolectomy or thrombolysis may be performed by a Heart and Vascular Center (HVC) interventional radiologist to remove the clot. In many cases these procedures can replace more invasive therapies, minimizing risk, leading to less pain and shorter recovery times than conventional surgery.

Pulmonary Embolism Response Team

Patients with a pulmonary embolism are initially evaluated by the HVC’s multidisciplinary Pulmonary Embolism Response Team (PERT), which includes pulmonologists and interventional radiologists, and a treatment plan is developed. Our PERT specialists are part of the Pulmonary and Critical Care Medicine clinical staff that provide advanced inpatient and outpatient services to diagnose, treat, and monitor a wide range of respiratory diseases for critically ill patients.

In Connecticut, only Yale New Haven Hospital has a dedicated 24/7 adult PERT program offering all medical, endovascular and surgical therapies for pulmonary embolism (PE) and deep vein thrombosis (DVT). We are only one of a few hospitals in the United States with a Pulmonary Embolism Response Team for pediatric patients. YNHH is an active participant in the National PERT Consortium where our specialists are advancing research, knowledge and treatment protocols aimed at increasing survival rates for patients across the world.

Hereditary Hemorrhagic Telangiectasia specialists

Yale New Haven Hospital Interventional Radiology collaborates with Yale Vascular Malformation Center, dedicated to treating and understanding vascular malformations of the brain, nose, lung, GI tract and extremities that may occur spontaneously or as part of rare genetic syndromes such as Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome.

The Yale Center, which is the model for 27 HHT Centers worldwide, manages 3,000 patients with HHT, including primary treatment and follow-up. Daily clinics for patients with vascular malformations, genetic counseling, evaluation and work-up for patients with gastrointestinal bleeding and liver, pulmonary and brain malformations associated with HHT are among the services offered. In addition to lecturing in the United States and overseas, the faculty publishes the results of their research regularly in a variety of peer-reviewed journals. Yale founded a non-profit foundation for HHT in 1991.